The Biomaterials Technologies Platform is an interdisciplinary research and development infrastructure that operates in close interaction with the Implantable Medical Device Technologies, Cell and Protein Technologies, and Nanomedicine Technologies platforms. Within the scope of the platform, biocompatible biomaterials are designed, prepared, characterized, and further developed for application-oriented use. These biomaterials are utilized in a wide range of areas including implantable medical device coatings, carrier systems for diagnostic applications, surfaces for protein immobilization, nanostructures for cell capture, wound dressings, and tissue engineering applications.

The platform is supported by the infrastructure of the Medical Device (Cleanroom) Unit and the Testing and Analysis Unit. This enables the integration of biomaterials into medical device and prototype development workflows, while also allowing comprehensive physical, chemical, microscopic, biological, and rheological characterization studies. In addition, the biocompatibility assessments and related analytical services provided through the Industrial Services Testing and Analysis Unit contribute directly to both academic research and industrial collaboration and product development processes. In this way, the platform serves not only as an enabling environment for advanced research, but also as a key convergence point for translational research and commercialization activities across other platforms.

For communication and further information, you may contact us via [email protected]